A new study reveals that the use of psychedelic-assisted therapy for treating depression and anxiety shows promising early results, with participants reporting significant reductions in symptoms after just a single session. Researchers highlight the potential of substances like psilocybin—found in "magic mushrooms"—when combined with professional therapy, suggesting a breakthrough in mental health treatment. The findings challenge conventional approaches and raise questions about the future of psychedelic research in clinical settings. Critics emphasize the need for further rigorous trials to confirm long-term safety and efficacy.